Health Minister Mike Nesbitt has approved plans for Northern Ireland’s first Regional Obesity Management Service (ROMS), with the initial phase due to open in early 2026. The announcement signals a shift towards offering NHS patients access to specialist weight-management support and medications already available elsewhere in the UK.
Given that 65 per cent of adults and 26 per cent of children in Northern Ireland live with overweight or obesity, the new service could have far-reaching implications for public health, healthcare costs and health inequalities.
What has been announced?
The Department of Health will establish ROMS in stages:
- Phase 1 (from early 2026): community-based clinics providing lifestyle advice and, where clinically appropriate, access to NICE-approved weight-loss drugs such as semaglutide (“weight-loss injections”).
- Later phases (subject to funding): potential development of bariatric surgery and other specialist interventions.
Mr Nesbitt said, “This is a very significant step forward. I have many competing demands on a seriously overstretched budget, but I was determined to prioritise this area.” He added that the phased rollout will ensure “treatment is provided in a safe and effective manner.”
Why it matters
Obesity costs Northern Ireland an estimated £414 million a year in healthcare and lost productivity (2015 figure). Those in deprived areas are disproportionately affected (68 per cent versus 62 per cent in the least deprived areas). Creating a regional service brings Northern Ireland in line with England, Scotland and Wales, potentially easing pressure on secondary care and tackling health inequalities.
Public consultation outcome
Nearly 19,000 people responded to the November 2023 consultation, with “overwhelming” support for the service and for the wider Healthy Futures obesity strategy, due in 2025. Respondents asked for a holistic, patient-centred approach, community engagement, and equitable access for marginalised groups.
What the press release leaves unclear
- Funding source and scale: The announcement does not specify how much ROMS will cost or where the money will come from within the “seriously overstretched budget.”
- Workforce capacity: There is no mention of staffing numbers, training plans or whether existing clinical teams will be expanded.
- Medication supply and eligibility: Details on prescribing criteria, duration of treatment and long-term medication costs are absent.
- Integration with preventive measures: The link between ROMS and broader public-health initiatives (active travel, food policy, school nutrition) is referenced but not explained.
- Rural access: It is not yet clear how community-based services will reach remote or rural populations.
Broader considerations
Across the UK, demand for new weight-loss drugs has surged, creating supply challenges and raising questions about cost-effectiveness. NICE guidance supports their use for some patients, yet long-term sustainability is unproven. Meanwhile, evidence suggests that prevention—improving diet, regulating junk-food marketing, increasing physical activity—still delivers the greatest population-level benefit.
It would be helpful to know how ROMS will complement the proposed Healthy Futures framework, which aims to foster systemic change. Without coordinated action on food environments, any clinic-based service risks treating symptoms rather than causes.
Questions to consider
- How will the Department of Health prioritise patients for weight-loss medication once ROMS opens in 2026?
- What proportion of the overall health budget has been earmarked for ROMS, and for how long?
- How will the service ensure equitable access for rural communities and those lacking reliable transport?
- In light of rising demand and limited supply, how will Northern Ireland secure a consistent stock of weight-loss medications?
- What preventive policies—beyond clinic-based treatment—will accompany ROMS to address the root causes of obesity?
Looking ahead
The Regional Obesity Management Service represents an important policy step towards tackling one of Northern Ireland’s most pressing public-health challenges. Final decisions on funding, workforce and integration with wider obesity-prevention measures will be critical. Stakeholders may wish to monitor the forthcoming Healthy Futures framework, expected in 2025, and any budget statements that clarify how this ambition will be turned into reality.